FrancophonIA/ELRC3.0 huggingface dataset:
English: Belgium Novartis Consumer Health SA/NV
Estonian: Novartis Consumer Health
English: An increased fluid intake is recommended for patients prone to formation of calculi in the urinary tract.
Estonian: Patsientidel, kellel esineb oht kivide moodustumiseks kuseteedes, soovitatakse tarvitada tavapärasest rohkem vedelikku.
English: In the case of persistent hypercalcaemia,
Estonian: Püsiva hüperkaltseemia korral tuleks välistada seisundit potentseerivate tegurite olemasolu,
English: Ca 500mg EEffervescent tablets
Estonian: 500mg effervescent
English: CALCIUM-SANDOZ 500mg compresse effervescenti
Estonian: 500mg compresse effervescenti
English: Calcium-Sandoz, brusetabletter Ca 500mg Effervescent tablets
Estonian: CALCIUM SANDOZ 500mg, comprimés effervescents
English: Novartis Consumer Health GmbH, Zielstattstrasse 40,
Estonian: Novartis Consumer Health SA/NV Medialaan, 30 Bus 5
English: Calcium-Sandoz 500mg Ca2+
Estonian: 500mg Ca2+ poretabletti
English: Sandoz Calcium forte, bruistabletten
Estonian: Sandoz Calcium forte,
English: Pharmacodynamic properties Pharmacotherapeutic group:
Estonian: Farmakodünaamilised omadused Farmakoterapeutiline grupp: Mineraalsed lisandid
English: Effects on ability to drive and use machines
Estonian: 4.2 Annustamine ja manustamisviis
English: Citric acid anhydrous (fine granulate)
Estonian: Veevaba sidrunhape (peengranulaarne)
English: Uncommon: Hypercalcaemia, hypercalciuria
Estonian: Ainevahetus- ja toitumishäired: Aeg-ajalt: Hüperkaltseemia, hüperkaltsiuuria
English: Attn: A. Catasus
Estonian: Catasus
English: It is available as capsules (5, 20, 100, 140, 180 and 250 mg).
Estonian: Ravimit turustatakse kapslitena (5 mg, 20 mg, 100 mg, 140 mg, 180 mg ja 250 mg).
English: The full EPAR for Temozolomide Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Temozolomide Teva kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Temozolomide Teva should be taken without food.
Estonian: Temozolomide Tevat tuleb võtta ilma toiduta.
English: As a result, the cancer cells cannot divide, slowing down the growth of tumours.
Estonian: Selle tulemusena ei saa vähirakud paljuneda ning see aeglustab kasvaja kasvu.
English: • adults with newly diagnosed glioblastoma multiforme (an aggressive type of malignant glioma).
Estonian: • Täiskasvanud, kellel on äsja diagnoositud multiformne glioblastoom (agressiivse kuluga pahaloomuline glioom).
English: The European Commission granted a marketing authorisation valid throughout the EU for Temozolomide Teva on 28 January 2010.
Estonian: Euroopa Komisjon andis Temozolomide Teva müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 28. jaanuaril 2010.
English: The dose of Temozolomide Teva depends on body surface area (calculated using the patient's height and weight) and ranges from 75 to 200 mg per square metre, once a day.
Estonian: Temozolomide Teva annus oleneb kehapindalast (arvutatakse patsiendi pikkuse ja kehamassi järgi) ning seda manustatakse 75-200 mg/m2 üks kord ööpäevas.
English: • adults and children three years of age and over with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, when the tumour has returned or got worse after standard treatment.
Estonian: • Täiskasvanud ja vähemalt 3-aastased lapsed, kellel on pahaloomuline glioom, näiteks multiformne glioblastoom või anaplastiline astrotsütoom, kui kasvaja on tavapärase ravi järel taastunud või progresseerunud.
English: It is used to treat malignant glioma (brain tumours) in the following groups of patients:
Estonian: Seda kasutatakse pahaloomulise glioomi (teatud ajukasvaja) ravimiseks järgmistel patsiendirühmadel:
English: MTIC binds to the DNA of cells while they are reproducing, which stops cell division.
Estonian: MTIC seondub rakkude paljunemise ajal nende DNAga, mis katkestab rakkude pooldumise.
English: This is a summary of the European public assessment report (EPAR) for Temozolomide Teva.
Estonian: See on Temozolomide Teva Euroopa avaliku hindamisaruande kokkuvõte.
English: The dose and the number of doses depend on the type of tumour being treated, whether the patient has been treated before, whether Temozolomide Teva is being used alone or with other treatments, and how the patient responds to treatment.
Estonian: Annus ja annuste arv sõltuvad ravitava kasvaja liigist, varasemast ravist, sellest, kas Temozolomide Tevat kasutatakse ainsa raviviisina või koos teistega, ja patsiendi ravivastusest.
English: For more information about treatment with Temozolomide Teva, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Temozolomide Tevaga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: The Committee recommended that Temozolomide Teva be given marketing authorisation.
Estonian: Komitee soovitas anda Temozolomide Teva müügiloa.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Temozolomide Teva.
Estonian: Selles selgitatakse, kuidas inimravimite komitee hindas ravimit ja otsustas toetada müügiloa andmist; samuti esitatakse komitee soovitused, kuidas ravimit kasutada.
English: The full EPAR for the reference medicine can also be found on the Agency's website.
Estonian: Euroopa avaliku hindamisaruande täistekst võrdlusravimite kohta on samuti Euroopa Ravimiameti veebilehel.
English: Therefore, the CHMP's view was that, as for Temodal, the benefit outweighs the identified risk.
Estonian: Seetõttu arvas inimravimite komitee, et nagu ka Temodali korral, ületab Temozolomide Teva kasulikkus sellega kaasnevad riskid.
English: Other information about Temozolomide Teva
Estonian: Muu teave Temozolomide Teva kohta
English: Temozolomide Teva should be used with caution in patients with severe liver problems or with kidney problems.
Estonian: Temozolomide Teva kasutamisel raskete maksa- või neeruprobleemidega patsientidel peab olema ettevaatlik.
English: Because Temozolomide Teva is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine.
Estonian: Et Temozolomide Teva on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: Temozolomide Teva temozolomide
Estonian: Temozolomide Teva temosolomiid
English: This means that Temozolomide Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called Temodal.
Estonian: See tähendab, et Temozolomide Teva on sarnane võrdlusravimiga Temodal, millel juba on Euroopa Liidus müügiluba.
English: The CHMP concluded that, in accordance with EU requirements, Temozolomide Teva has been shown to have comparable quality and to be bioequivalent to Temodal.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud ravimi Temozolomide Teva võrdväärne kvaliteet ja bioekvivalentsus ravimiga Temodal.
English: What is Temozolomide Teva?
Estonian: Mis on Temozolomide Teva?
English: Because Temozolomide Teva is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine, Temodal.
Estonian: Et Temozolomide Teva on geneeriline ravim, piirdusid uuringud katsetega, milles näidati Temozolomide Teva bioekvivalentsust võrdlusravimiga Temodal.
English: Patients may also need to take medicines to prevent vomiting before taking Temozolomide Teva.
Estonian: Enne Temozolomide Teva võtmist võib olla vaja manustada oksendamist ennetavaid ravimeid.
English: Treatment with Temozolomide Teva should be prescribed by a doctor with experience in the treatment of brain tumours.
Estonian: Ravi Temozolomide Tevaga võib määrata vaid ajukasvajate ravis kogenud arst.
English: Temozolomide Teva is a medicine that contains the active substance temozolomide.
Estonian: Temozolomide Teva on ravim, mis sisaldab toimeainena temosolomiidi.
English: Why has Temozolomide Teva been approved?
Estonian: Miks Temozolomide Teva heaks kiideti?
English: The active substance in Temozolomide Teva, temozolomide, belongs to a group of cancer medicines called alkylating agents.
Estonian: Temozolomide Teva toimeaine temosolomiid kuulub alküleerivateks aineteks nimetatavate vähiravimite rühma.
English: Temozolomide Teva is a ‘generic medicine'.
Estonian: Temozolomide Teva on geneeriline ravim.
English: Temozolomide Teva is used first with radiotherapy and then on its own;
Estonian: Temozolomide Tevat kasutatakse esialgu koos kiiritusraviga ning seejärel ainsa raviviisina.
English: Temozolomide Teva is a cancer medicine.
Estonian: Temozolomide Teva on vähiravim.
English: What are the benefits and risks of Temozolomide Teva?
Estonian: Milles seisneb Temozolomide Teva kasulikkus ja mis riskid ravimiga kaasnevad?
English: How has Temozolomide Teva been studied?
Estonian: Kuidas Temozolomide Tevat uuriti?
English: How does Temozolomide Teva work?
Estonian: Kuidas Temozolomide Teva toimib?
English: What is Temozolomide Teva used for?
Estonian: Milleks Temozolomide Tevat kasutatakse?
English: How is Temozolomide Teva used?
Estonian: Kuidas Temozolomide Tevat kasutatakse?
English: In the body, temozolomide is converted to another compound called MTIC.
Estonian: Organismis muundub temosolomiid 5-(3-metüül-1-triaseno-)-imidasool-4-karboksamiidiks (MTIC).
English: Temozolomide Teva is used on its own in these patients.
Estonian: Nendel patsientidel kasutatakse Temozolomide Tevat ainsa raviviisina.
English: Stimulants (analeptics) must not be used.
Estonian: Stimulante (analeptikume) ei tohi kasutada.
English: Patients should be carefully monitored.
Estonian: Patsiente tuleb hoolikalt jälgida.
English: The tablet may be taken with or without food.
Estonian: Tableti võib võtta koos toiduga või ilma.
English: Not known: frequency cannot be estimated from the available data • abnormal behaviour
Estonian: Teadmata: esinemissagedust ei saa hinnata olemasolevate andmete alusel • ebanormaalne käitumine
English: Patients should be informed that most people do not experience drowsiness.
Estonian: Patsiente tuleb teavitada, et enamikel inimestel ei teki uimasust.
English: Swallow the tablet whole with water.
Estonian: Neelata tablett tervelt koos veega.
English: Aerinaze with alcohol
Estonian: Aerinaze koos alkoholiga
English: If you forget to take your dose on time, take it as soon as possible and then go back to your regular dosing schedule.
Estonian: Kui unustasite ravimit võtta õigel ajal, tehke seda nii ruttu kui saate ja pöörduge pärast seda tagasi tavapärase annustamisskeemi juurde.
English: Other medicines and Aerinaze
Estonian: Muud ravimid ja Aerinaze
English: Risks of abuse
Estonian: Kuritarvitamise ohud
English: Do not crush, break or chew.
Estonian: Mitte purustada, murda või närida.
English: • digitalis (see section 4.4)
Estonian: • digitaalis (vt lõik 4.4);
English: Frequencies are defined as very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000) and not known (cannot be estimated from the available data).
Estonian: Esinemissagedused on määratletud kui väga sage (≥ 1/10), sage (≥ 1/100 kuni < 1/10), aeg-ajalt (≥ 1/1000 kuni < 1/100), harv (≥ 1/10 000 kuni < 1/1000), väga harv (< 1/10 000) ja teadmata (ei saa hinnata olemasolevate andmete alusel).
English: Older adults may be more sensitive to the effects of this medicine - if you have diabetes
Estonian: Vanemad inimesed võivad olla selle ravimi suhtes tundlikumad; - kui teil on diabeet;
English: If you are scheduled to have surgery, your doctor may advise you to stop taking Aerinaze 24 hours beforehand.
Estonian: Kui teile planeeritakse teha kirurgilist operatsiooni, võib teie arst soovitada teil Aerinaze'i võtmise lõpetada 24 tundi enne seda.
English: The half-life for desloratadine is 27.4 hours.
Estonian: Desloratadiini poolväärtusaeg on 27,4 tundi.
English: The recommended dosage and the duration of treatment should not be exceeded.
Estonian: Soovitatud annust ja ravi kestust ei tohi ületada.
English: What you need to know before you take Aerinaze
Estonian: Mida on vaja teada enne Aerinaze'i võtmist
English: Adverse reactions considered by investigators to be causally related to Aerinaze are listed below by System Organ Class.
Estonian: Kõrvaltoimed, mida uurijad arvasid olevat põhjuslikult seotud Aerinaze'iga, on loetletud allpool vastavalt organsüsteemi klassile.
English: Do not take this medicine for more than 10 days continuously unless your doctor tells you to do so.
Estonian: Ärge võtke seda ravimit üle 10 päeva järjest, kui arst ei ole teisiti määranud.
English: Date of first authorisation: 30 July 2007 Date of latest renewal: 30 July 2012
Estonian: Müügiloa esmase väljastamise kuupäev: 30/07/2007 Müügiloa viimase uuendamise kuupäev: 30/07/2012
English: The enzyme responsible for the metabolism of desloratadine has not been identified yet, and therefore, some interactions with other medicinal products cannot be fully excluded.
Estonian: Desloratadiini metaboliseerivat ensüümi ei ole veel kindlaks tehtud ning seetõttu ei saa täielikult välistada mõningaid koostoimeid teiste ravimitega.
English: The following combinations are not recommended:
Estonian: Kombinatsioonid järgmiste ravimitega ei ole soovitatavad:
English: In adults, tap water can be used.
Estonian: Täiskasvanutel võib kasutada kraanivett.
English: After emergency treatment, medical monitoring of the patient should be continued.
Estonian: Pärast esmaabi tuleb jätkata patsiendi meditsiinilist jälgimist.
English: In the event of overdose, symptomatic and supportive treatment immediately should be started and maintained it for as long as necessary.
Estonian: Üleannustamise korral tuleb viivitamatult rakendada sümptomaatilist ja toetavat ravi, jätkates seda nii kaua kui vajalik.
English: The duration of treatment should be kept as short as possible and should not be continued after the symptoms have disappeared.
Estonian: Ravikuuri pikkus peab olema nii lühike kui võimalik ja ravi tuleb lõpetada kohe, kui sümptomid on kadunud.
English: Continuous use can lead to tolerance resulting in an increased risk of overdosing.
Estonian: Pidev kasutamine võib tekitada tolerantsust, mis omakorda suurendab üleannustamise ohtu.
English: What Aerinaze is and what it is used for What you need to know before you take Aerinaze How to take Aerinaze
Estonian: Mis ravim on Aerinaze ja milleks seda kasutatakse Mida on vaja teada enne Aerinaze'i võtmist Kuidas Aerinaze'i võtta
English: These effects may be more likely to occur in adolescents from 12 years old, elderly patients, or in cases of overdose (see section 4.9).
Estonian: Need toimed võivad tõenäolisemalt esineda 12-aastastel ja vanematel noorukitel, eakatel patsientidel või üleannustamise korral (vt lõik 4.9).
English: Use in children and adolescents Do not give this medicine to children less than 12 years of age.
Estonian: Kasutamine lastel ja noorukitel Ärge andke seda ravimit alla 12-aastastele lastele.
English: If you forget to take Aerinaze
Estonian: Kui te unustate Aerinaze'i võtta
English: • changes in frequency of urination
Estonian: • muutused urineerimissageduses
English: Adults and adolescents 12 years of age and over The recommended dose is one tablet twice daily with a glass of water, with or without food.
Estonian: Täiskasvanud ja 12-aastased ning vanemad noorukid Soovitatav annus on üks tablett kaks korda ööpäevas koos klaasitäie veega, koos toiduga või ilma.
English: Aerinaze has no or negligible influence on the ability to drive and use machines.
Estonian: Aerinaze'il ei ole või on ebaoluline toime autojuhtimise ja masinate käsitsemise võimele.
English: Symptoms of overdose are mostly of a sympathomimetic nature.
Estonian: Üleannustamise sümptomid on enamasti sümpatomimeetilise olemusega.
English: Do not take tablets more often than recommended.
Estonian: Ärge võtke tablette sagedamini kui ette nähtud.
English: Some patients may present a toxic psychosis with delusions and hallucinations.
Estonian: Mõnedel patsientidel võib tekkida toksiline psühhoos koos vääraistingute ja hallutsinatsioonidega.
English: The following side effects have been seen in studies:
Estonian: Uuringutes on täheldatud järgnevaid kõrvaltoimeid:
English: The safety and efficacy of Aerinaze in children below the age of 12 years have not been established.
Estonian: Aerinaze'i ohutus ja efektiivsus lastel vanuses alla 12-aasta ei ole tõestatud.
English: Treatment of the pseudoephedrine sulphate overdose is symptomatic and supportive.
Estonian: Pseudoefedriinsulfaadi üleannustamise ravi on sümptomaatiline ja toetav.
English: • tricyclic antidepressants and other antihistamines.
Estonian: • tritsüklilised antidepressandid ja teised antihistamiinikumid.
English: In clinical trials involving 414 adults the most frequent of adverse reactions reported were insomnia (8.9 %), dry mouth (7.2 %) and headache (3.1 %).
Estonian: Kliinilistes uuringustes, kus osales 414 täiskasvanud patsienti, olid kõige sagedasemateks kõrvaltoimeteks unetus (8,9%), suukuivus (7,2%) ja peavalu (3,1%).
English: Distribution Desloratadine is moderately bound (83 % - 87 %) to plasma proteins.
Estonian: Jaotumine Desloratadiin seondub mõõdukalt plasmavalkudega (83%-87%).
English: These include:
Estonian: Siia kuuluvad:
English: Swallow the tablet whole; do not crush, break or chew the tablet before swallowing.
Estonian: Neelake tablett alla tervelt; ärge purustage, murdke ega närige tabletti enne neelamist.
English: What Aerinaze is and what it is used for
Estonian: Mis ravim on Aerinaze ja milleks seda kasutatakse
English: 2220 Heist-op-den-Berg Belgium
Estonian: 2220 Heist-op-den-Berg Belgia
English: As a precautionary measure, it is preferable to avoid the use of Aerinaze during pregnancy.
Estonian: Ettevaatuse mõttes on parem vältida Aerinaze'i kasutamist raseduse ajal.
English: Keep the blisters in the outer carton in order to protect from light.
Estonian: Hoida blistreid välispakendis, valguse eest kaitstult.
English: There were no significant differences in the efficacy of Aerinaze tablets across subgroups of patients defined by gender, age, or race.
Estonian: Aerinaze'i tablettide efektiivsus ei erinenud märkimisväärselt patsientide soo, vanuse või rassi põhjal moodustatud alarühmades.
English: The interaction with Aerinaze and alcohol has not been studied.
Estonian: Aerinaze'i ja alkoholi koostoimeid ei ole uuritud.
English: The active substance and its metabolite are excreted in urine; 55-75 % of the administered dose is excreted unchanged.
Estonian: Toimeaine ja selle metaboliit erituvad uriiniga; 55...75% manustatud annusest eritub muutumatul kujul.
English: What Aerinaze looks like and contents of the pack
Estonian: Kuidas Aerinaze välja näeb ja pakendi sisu
English: Very rarely: the following other side effects reported during the marketing of desloratadine, may affect up to 1 in 10,000 people
Estonian: Väga harv: järgnevad muud desloratadiini turustamise ajal teatatud kõrvaltoimed võivad esineda kuni ühel inimesel 10 000st:
English: Aerinaze is also contraindicated in patients with:
Estonian: Aerinaze on vastunäidustatud ka patsientidele, kellel on:
English: Desloratadine does not inhibit CYP3A4 in vivo, and in vitro studies have shown that the medicinal product does not inhibit CYP2D6 and is neither a substrate nor an inhibitor of P-glycoprotein.
Estonian: Desloratadiin ei pärsi in vivo ensüümi CYP3A4 ja in vitro uuringutes on näidatud, et ravim ei pärsi ensüümi CYP2D6 ning ei ole substraadiks ega inhibiitoriks P-glükoproteiinile.
English: Other adverse reactions reported for desloratadine during the post-marketing period are listed hereunder.
Estonian: Teised desloratadiini kõrvaltoimed, millest on teatatud ravimi turustamise ajal, on loetletud alljärgnevalt.
English: The tablet may be taken with a full glass of water but must be swallowed entirely (without crushing, breaking or chewing it).
Estonian: Tableti võib võtta koos klaasitäie veega; see tuleb tervena alla neelata (tabletti ei tohi purustada, katki murda ega närida).
English: • increased sugar in blood
Estonian: • vere suhkrusisalduse suurenemine
English: It has an indirect sympathomimetic effect due primarily to the release of adrenergic mediators from the post-ganglionic nerve endings.
Estonian: Tal on kaudne sümpatomimeetiline toime tänu peamiselt adrenergiliste mediaatorite vabanemisele postganglionaarsetest närvilõpmetest.
English: The clinical efficacy and safety of Aerinaze tablets was evaluated in two, 2-week multicentre, randomized parallel group clinical trials involving 1,248 patients 12 to 78 years of age with seasonal allergic rhinitis, 414 of whom received Aerinaze tablets.
Estonian: Aerinaze'i tablettide kliinilist efektiivsust ja ohutust hinnati kahes 2-nädalases mitmekeskuselises randomiseeritud paralleelsete rühmadega kliinilises uuringus, kus osales 1248 sesoonse allergilise riniidiga patsienti vanuses 12 kuni 78 aastat.
English: EU/1/07/399/001 2 modified-release tablets EU/1/07/399/002 4 modified-release tablets EU/1/07/399/003 7 modified-release tablets EU/1/07/399/004 10 modified-release tablets EU/1/07/399/005 14 modified-release tablets EU/1/07/399/006 20 modified-release tablets
Estonian: EU/1/07/399/001 2 toimeainet modifitseeritult vabastavat tabletti EU/1/07/399/002 4 toimeainet modifitseeritult vabastavat tabletti EU/1/07/399/003 7 toimeainet modifitseeritult vabastavat tabletti EU/1/07/399/004 10 toimeainet modifitseeritult vabastavat tabletti EU/1/07/399/005 14 toimeainet modifitseeritult vabastavat tabletti EU/1/07/399/006 20 toimeainet modifitseeritult vabastavat tabletti
English: Stop taking Aerinaze at least 48 hours before you have any skin tests since antihistamines may influence the result of the skin test.
Estonian: Lõpetage Aerinaze'i võtmine vähemalt 48 tundi enne nahatestide tegemist, sest antihistamiinikumid võivad mõjutada nahatestide tulemust.
English: As much as possible of the amount administered should be removed before the next instillation.
Estonian: Enne järgmist tilgutamist tuleb eemaldada võimalikult palju vedelikku.
English: Do not take more tablets than recommended on the label.
Estonian: Ärge võtke tablette rohkem kui on soovitatud.
English: • problems urinating
Estonian: • probleemid urineerimisel
English: Continuous use may lead to taking more Aerinaze than the recommended dose to get the desired effect, resulting in an increased risk of overdosing.
Estonian: Pideval kasutamisel võib juhtuda, et kogemata võetakse suurem Aerinaze'i annus, kui oodatud toime saavutamiseks vajalik soovitatav annus; tulemuseks suurem üleannustamise risk.
English: Aerinaze is not recommended for use in children below the age of 12 years.
Estonian: Aerinaze'i ei soovitata kasutada alla 12-aastastel lastel.
English: The combination was not more toxic than their individual components, and observed effects were generally related to the pseudoephedrine sulphate component.
Estonian: Kombinatsioon ei olnud mürgisem kui ravimi komponendid ühekaupa ning täheldatud nähud olid seotud peamiselt pseudoefedriinsulfaadiga.
English: As Aerinaze contains pseudoephedrine sulphate, it is also contraindicated in patients who are receiving monoamine oxidase (MAO) inhibitor therapy or during the 2 weeks following the stopping of such treatment.
Estonian: Et Aerinaze sisaldab pseudoefedriinsulfaati, on ravim vastunäidustatud ka patsientidele, kes saavad samaaegselt ravi monoamiini oksüdaasi (MAO) inhibiitoritega ja kahe nädala jooksul pärast sellise ravi lõpetamist.
English: Speak with your doctor, pharmacist or nurse regarding whether you can drink alcohol while taking Aerinaze.
Estonian: Küsige oma arstilt, apteekrilt või meditsiiniõelt, kas te võite Aerinaze'i võtmise ajal tarbida alkoholi.